| NCT ID | NCT06860646 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ryazan State Medical University |
| Condition | Myocardial Infarction (MI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-09-01 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2020-09-01 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An observational registry study of patients aged 75 years and older with an established diagnosis of myocardial infarction, initiated in 2020, with an assessment of clinical, instrumental, demographic and prognostic data. Statistical analysis was performed using the StatTech v. 4.5.0 program (developer - StatTech LLC, Russia). Differences were considered statistically significant at p \<0.05.
Eligibility Criteria
Inclusion Criteria: \- age 75 years and older, presence of an established diagnosis of myocardial infarction at the time of hospitalization. Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06860646 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Myocardial Infarction (MI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06860646 currently recruiting?
Yes, NCT06860646 is actively recruiting participants. Contact the research team at gurbanovaarzu2@gmail.com for enrollment information.
Where is the NCT06860646 trial being conducted?
This trial is being conducted at Ryazan, Russia.
Who is sponsoring the NCT06860646 clinical trial?
NCT06860646 is sponsored by Ryazan State Medical University. The trial plans to enroll 1,000 participants.